[Effects of bamifylline and of combined bamifylline and phenylpropanolamine in reversible respiratory obstruction].
D000605:Amino Alcohols / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D008722:Methods; D010627:Phenethylamines / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use; D010919:Placebos; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D013566:Sympathomimetics; D010665:Phenylpropanolamine
Etude des effets de la bamifylline et de l'association de bamifylline et de phénylpropanolamine dans les obstructions ventilatoires réversibles.